Eficacia de ciprofloxacina 1 gramo de liberación prolongada en toma única en infección del tracto urinario bajo, en pacientes de sexo femenino mayores de 18 años , Hospital Vicente Corral Moscoso, mayo-julio 2013

Abstract

Objective: Evaluate the effectiveness of ciprofloxacin extended-release scheme in 1 gram single dose for 5 days in the treatment of low urinary tract infection (UTI) in women over 18 years of HVCM Outpatient.

Methodology: This is a retrospective documentary analytical study was conducted at the Outpatient HVCM of female patients with UTI low diagnosed over 18 years; this population after getting informed consent was receiving ciprofloxacin treated 1 gram taken once daily for 5 days; by this study the effectiveness of the proposed scheme, evidenced by the results of culture and uro clinical improvement before and after the treatment regimen was evaluated.

Results: A sample of 110 patients who had UTIs low, with a mean age of 44.4 years, with urban areas (81.4%) was studied. Those who underwent a preculture treatment and one post-treatment with ciprofloxacin extended-release 1000 mg in single dose in five days. Where the most frequently isolated microorganism was E. coli (71.82%).

The rate of disappearance of symptoms was 97.03% in the population studied post-treatment. With the most common symptom was urinary frequency. The average disappearance of symptoms was 2 days.

Conclusion: The use of ciprofloxacin extended-release 1000 mg in single dose for 5 days is effective in the treatment of lower UTI.

KEYWORDS: ITU, QUINOLONE, SYMPTOMS, CULTURE, CIPROFLOXACIN EXTENDED RELEASE